Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Technology forecast: advanced therapies in late clinical research, EMA approval or clinical application via hospital exemption.

Eder C, Wild C.

J Mark Access Health Policy. 2019 Apr 19;7(1):1600939. doi: 10.1080/20016689.2019.1600939. eCollection 2019. Review.

2.

Hamate's coronal fracture: diagnostic and therapeutic approaches based on a long-term follow-up.

Eder C, Scheller A, Schwab N, Krapohl BD.

GMS Interdiscip Plast Reconstr Surg DGPW. 2019 Mar 29;8:Doc05. doi: 10.3205/iprs000131. eCollection 2019.

3.

Impact of assay procedures on detection of MR4.5 status in chronic myeloid leukemia: Optimization of cDNA synthesis.

Jeromin S, Eder C, Haferlach C, Haferlach T, Kern W.

Int J Lab Hematol. 2019 Oct;41(5):e109-e112. doi: 10.1111/ijlh.13004. Epub 2019 Mar 12. No abstract available.

PMID:
30860652
4.

Warmth and competence predict overoptimistic beliefs for out-group but not in-group members.

Dricu M, Bührer S, Hesse F, Eder C, Posada A, Aue T.

PLoS One. 2018 Nov 26;13(11):e0207670. doi: 10.1371/journal.pone.0207670. eCollection 2018.

5.

Sustainability of a Community-Based CHOICE Program to Improve the Health and Nutrition Status of Mothers and Infants in Indonesia.

Eder C, Khatiwada LK, Schooley J.

Matern Child Health J. 2018 Jun;22(6):903-912. doi: 10.1007/s10995-018-2465-6.

PMID:
29429132
6.

Boron-Based Inhibitors of the NLRP3 Inflammasome.

Baldwin AG, Rivers-Auty J, Daniels MJD, White CS, Schwalbe CH, Schilling T, Hammadi H, Jaiyong P, Spencer NG, England H, Luheshi NM, Kadirvel M, Lawrence CB, Rothwell NJ, Harte MK, Bryce RA, Allan SM, Eder C, Freeman S, Brough D.

Cell Chem Biol. 2017 Nov 16;24(11):1321-1335.e5. doi: 10.1016/j.chembiol.2017.08.011. Epub 2017 Sep 21.

7.

Lysophosphatidylcholine activates caspase-1 in microglia via a novel pathway involving two inflammasomes.

Scholz H, Eder C.

J Neuroimmunol. 2017 Sep 15;310:107-110. doi: 10.1016/j.jneuroim.2017.07.004. Epub 2017 Jul 10.

PMID:
28778433
8.

Safety and tolerability of topically administered autologous, apoptotic PBMC secretome (APOSEC) in dermal wounds: a randomized Phase 1 trial (MARSYAS I).

Simader E, Traxler D, Kasiri MM, Hofbauer H, Wolzt M, Glogner C, Storka A, Mildner M, Gouya G, Geusau A, Fuchs C, Eder C, Graf A, Schaden M, Golabi B, Aretin MB, Suessner S, Gabriel C, Klepetko W, Tschachler E, Ankersmit HJ.

Sci Rep. 2017 Jul 24;7(1):6216. doi: 10.1038/s41598-017-06223-x.

9.

Effects on the Distal Radioulnar Joint of Ablation of Triangular Fibrocartilage Complex Tears With Radiofrequency Energy.

Huber M, Loibl M, Eder C, Kujat R, Nerlich M, Gehmert S.

J Hand Surg Am. 2016 Nov;41(11):1080-1086. doi: 10.1016/j.jhsa.2016.08.013. Epub 2016 Sep 20.

PMID:
27663055
10.

Graftless Full-Arch Implant Rehabilitation with Interantral Implants and Immediate or Delayed Loading-Part II: Transition from the Failing Maxillary Dentition.

Busenlechner D, Mailath-Pokorny G, Haas R, Fürhauser R, Eder C, Pommer B, Watzek G.

Int J Oral Maxillofac Implants. 2016 Sep-Oct;31(5):1150-5. doi: 10.11607/jomi.4326.

PMID:
27632272
11.

Mechanisms Underlying Interferon-γ-Induced Priming of Microglial Reactive Oxygen Species Production.

Spencer NG, Schilling T, Miralles F, Eder C.

PLoS One. 2016 Sep 6;11(9):e0162497. doi: 10.1371/journal.pone.0162497. eCollection 2016.

12.

Fenamate NSAIDs inhibit the NLRP3 inflammasome and protect against Alzheimer's disease in rodent models.

Daniels MJ, Rivers-Auty J, Schilling T, Spencer NG, Watremez W, Fasolino V, Booth SJ, White CS, Baldwin AG, Freeman S, Wong R, Latta C, Yu S, Jackson J, Fischer N, Koziel V, Pillot T, Bagnall J, Allan SM, Paszek P, Galea J, Harte MK, Eder C, Lawrence CB, Brough D.

Nat Commun. 2016 Aug 11;7:12504. doi: 10.1038/ncomms12504.

13.

Graftless Full-Arch Implant Rehabilitation with Interantral Implants and Immediate or Delayed Loading-Part I: Reconstruction of the Edentulous Maxilla.

Busenlechner D, Mailath-Pokorny G, Haas R, Fürhauser R, Eder C, Pommer B, Watzek G.

Int J Oral Maxillofac Implants. 2016 Jul-Aug;31(4):900-5. doi: 10.11607/jomi.4325.

PMID:
27447159
14.

Critical data-based re-evaluation of minocycline as a putative specific microglia inhibitor.

Möller T, Bard F, Bhattacharya A, Biber K, Campbell B, Dale E, Eder C, Gan L, Garden GA, Hughes ZA, Pearse DD, Staal RG, Sayed FA, Wes PD, Boddeke HW.

Glia. 2016 Oct;64(10):1788-94. doi: 10.1002/glia.23007. Epub 2016 Jun 1. Review.

PMID:
27246804
15.

KCa 3.1-a microglial target ready for drug repurposing?

Dale E, Staal RG, Eder C, Möller T.

Glia. 2016 Oct;64(10):1733-41. doi: 10.1002/glia.22992. Epub 2016 Apr 28. Review.

PMID:
27121595
16.

A new variant of scaphoid reconstruction: Treatment of scaphoid non-union with avascular bone interponate and high compression screw (Synthes(®)).

Eder C, Schwab N, Scheller A, Krapohl BD.

GMS Interdiscip Plast Reconstr Surg DGPW. 2015 Aug 24;4:Doc07. doi: 10.3205/iprs000066. eCollection 2015.

17.

Molecular subtypes of NPM1 mutations have different clinical profiles, specific patterns of accompanying molecular mutations and varying outcomes in intermediate risk acute myeloid leukemia.

Alpermann T, Schnittger S, Eder C, Dicker F, Meggendorfer M, Kern W, Schmid C, Aul C, Staib P, Wendtner CM, Schmitz N, Haferlach C, Haferlach T.

Haematologica. 2016 Feb;101(2):e55-8. doi: 10.3324/haematol.2015.133819. Epub 2015 Oct 15. No abstract available.

18.

Evaluation of IDH1G105 polymorphism as prognostic marker in intermediate-risk AML.

Fasan A, Haferlach C, Eder C, Alpermann T, Quante A, Peters A, Kern W, Haferlach T, Schnittger S.

Ann Hematol. 2015 Dec;94(12):1991-2001. doi: 10.1007/s00277-015-2488-7. Epub 2015 Sep 9.

PMID:
26351014
19.

Microglial Kv1.3 Channels and P2Y12 Receptors Differentially Regulate Cytokine and Chemokine Release from Brain Slices of Young Adult and Aged Mice.

Charolidi N, Schilling T, Eder C.

PLoS One. 2015 May 26;10(5):e0128463. doi: 10.1371/journal.pone.0128463. eCollection 2015.

20.

Does intrawound application of vancomycin influence bone healing in spinal surgery?

Eder C, Schenk S, Trifinopoulos J, Külekci B, Kienzl M, Schildböck S, Ogon M.

Eur Spine J. 2016 Apr;25(4):1021-8. doi: 10.1007/s00586-015-3943-9. Epub 2015 Apr 24.

PMID:
25904413
21.
22.

RFE based chondroplasty in wrist arthroscopy indicates high risk for chrondocytes especially for the bipolar application.

Huber M, Eder C, Loibl M, Berner A, Zellner J, Kujat R, Nerlich M, Gehmert S.

BMC Musculoskelet Disord. 2015 Jan 31;16:6. doi: 10.1186/s12891-015-0460-2.

23.

AML with gain of chromosome 8 as the sole chromosomal abnormality (+8sole) is associated with a specific molecular mutation pattern including ASXL1 mutations in 46.8% of the patients.

Alpermann T, Haferlach C, Eder C, Nadarajah N, Meggendorfer M, Kern W, Haferlach T, Schnittger S.

Leuk Res. 2015 Mar;39(3):265-72. doi: 10.1016/j.leukres.2014.11.026. Epub 2014 Dec 16.

PMID:
25592059
24.

Refractory anemia with ring sideroblasts and marked thrombocytosis cases harbor mutations in SF3B1 or other spliceosome genes accompanied by JAK2V617F and ASXL1 mutations.

Jeromin S, Haferlach T, Weissmann S, Meggendorfer M, Eder C, Nadarajah N, Alpermann T, Kohlmann A, Kern W, Haferlach C, Schnittger S.

Haematologica. 2015 Apr;100(4):e125-7. doi: 10.3324/haematol.2014.119032. Epub 2014 Dec 19. No abstract available.

25.

Temperature in and around the scapholunate ligament during radiofrequency shrinkage: a cadaver study.

Huber M, Loibl M, Eder C, Zellner J, Kujat R, Nerlich M, Gehmert S.

J Hand Surg Am. 2015 Feb;40(2):259-65. doi: 10.1016/j.jhsa.2014.10.030. Epub 2014 Dec 12.

PMID:
25500298
26.

Microglial K(+) channel expression in young adult and aged mice.

Schilling T, Eder C.

Glia. 2015 Apr;63(4):664-72. doi: 10.1002/glia.22776. Epub 2014 Dec 3.

27.

A CMOS smart temperature and humidity sensor with combined readout.

Eder C, Valente V, Donaldson N, Demosthenous A.

Sensors (Basel). 2014 Sep 16;14(9):17192-211. doi: 10.3390/s140917192.

28.

TRPM7 regulates proliferation and polarisation of macrophages.

Schilling T, Miralles F, Eder C.

J Cell Sci. 2014 Nov 1;127(Pt 21):4561-6. doi: 10.1242/jcs.151068. Epub 2014 Sep 9.

29.

An Implantable Versatile Electrode-Driving ASIC for Chronic Epidural Stimulation in Rats.

Giagka V, Eder C, Donaldson N, Demosthenous A.

IEEE Trans Biomed Circuits Syst. 2015 Jun;9(3):387-400. doi: 10.1109/TBCAS.2014.2330859. Epub 2014 Aug 13.

PMID:
25134089
30.

WT1 mutations are secondary events in AML, show varying frequencies and impact on prognosis between genetic subgroups.

Krauth MT, Alpermann T, Bacher U, Eder C, Dicker F, Ulke M, Kuznia S, Nadarajah N, Kern W, Haferlach C, Haferlach T, Schnittger S.

Leukemia. 2015 Mar;29(3):660-7. doi: 10.1038/leu.2014.243. Epub 2014 Aug 11.

PMID:
25110071
31.

The impact of arterial vessel injuries associated with pediatric supracondylar humeral fractures.

Wegmann H, Eberl R, Kraus T, Till H, Eder C, Singer G.

J Trauma Acute Care Surg. 2014 Aug;77(2):381-5. doi: 10.1097/TA.0000000000000306.

PMID:
25058268
32.

Rare coincident NPM1 and RUNX1 mutations in intermediate risk acute myeloid leukemia display similar patterns to single mutated cases.

Fasan A, Haferlach C, Kohlmann A, Dicker F, Eder C, Kern W, Haferlach T, Schnittger S.

Haematologica. 2014 Feb;99(2):e20-1. doi: 10.3324/haematol.2013.099754. No abstract available.

33.

BAALC expression: a suitable marker for prognostic risk stratification and detection of residual disease in cytogenetically normal acute myeloid leukemia.

Weber S, Alpermann T, Dicker F, Jeromin S, Nadarajah N, Eder C, Fasan A, Kohlmann A, Meggendorfer M, Haferlach C, Kern W, Haferlach T, Schnittger S.

Blood Cancer J. 2014 Jan 10;4:e173. doi: 10.1038/bcj.2013.71.

34.

High number of additional genetic lesions in acute myeloid leukemia with t(8;21)/RUNX1-RUNX1T1: frequency and impact on clinical outcome.

Krauth MT, Eder C, Alpermann T, Bacher U, Nadarajah N, Kern W, Haferlach C, Haferlach T, Schnittger S.

Leukemia. 2014 Jul;28(7):1449-58. doi: 10.1038/leu.2014.4. Epub 2014 Jan 9.

PMID:
24402164
35.

The role of different genetic subtypes of CEBPA mutated AML.

Fasan A, Haferlach C, Alpermann T, Jeromin S, Grossmann V, Eder C, Weissmann S, Dicker F, Kohlmann A, Schindela S, Kern W, Haferlach T, Schnittger S.

Leukemia. 2014 Apr;28(4):794-803. doi: 10.1038/leu.2013.273. Epub 2013 Sep 23.

PMID:
24056881
36.

Patch clamp protocols to study ion channel activity in microglia.

Schilling T, Eder C.

Methods Mol Biol. 2013;1041:163-82. doi: 10.1007/978-1-62703-520-0_17.

PMID:
23813379
37.

Fluorescence imaging of intracellular Ca2+, Na+, and H+ in cultured microglia.

Schilling T, Eder C.

Methods Mol Biol. 2013;1041:147-61. doi: 10.1007/978-1-62703-520-0_16.

PMID:
23813378
38.

Acute erythroid leukemia (AEL) can be separated into distinct prognostic subsets based on cytogenetic and molecular genetic characteristics.

Grossmann V, Bacher U, Haferlach C, Schnittger S, Pötzinger F, Weissmann S, Roller A, Eder C, Fasan A, Zenger M, Staller M, Kern W, Kohlmann A, Haferlach T.

Leukemia. 2013 Sep;27(9):1940-3. doi: 10.1038/leu.2013.144. Epub 2013 May 7. No abstract available.

PMID:
23648669
39.

Analysis of a β-TCP bone graft extender explanted during revision surgery after 28 months in vivo.

Eder C, Meissner J, Bretschneider W, Schildböck S, Ogon M.

Eur Spine J. 2014 May;23 Suppl 2:157-60. doi: 10.1007/s00586-013-2802-9. Epub 2013 May 1.

PMID:
23636843
40.

Influence of intradiscal medication on nucleus pulposus cells.

Eder C, Pinsger A, Schildboeck S, Falkner E, Becker P, Ogon M.

Spine J. 2013 Nov;13(11):1556-62. doi: 10.1016/j.spinee.2013.03.021. Epub 2013 Apr 19.

PMID:
23608563
41.

High incidence of RAS signalling pathway mutations in MLL-rearranged acute myeloid leukemia.

Grossmann V, Schnittger S, Poetzinger F, Kohlmann A, Stiel A, Eder C, Fasan A, Kern W, Haferlach T, Haferlach C.

Leukemia. 2013 Sep;27(9):1933-6. doi: 10.1038/leu.2013.90. Epub 2013 Mar 28. No abstract available.

PMID:
23535558
42.

CEBPA double-mutated acute myeloid leukaemia harbours concomitant molecular mutations in 76·8% of cases with TET2 and GATA2 alterations impacting prognosis.

Grossmann V, Haferlach C, Nadarajah N, Fasan A, Weissmann S, Roller A, Eder C, Stopp E, Kern W, Haferlach T, Kohlmann A, Schnittger S.

Br J Haematol. 2013 Jun;161(5):649-58. doi: 10.1111/bjh.12297. Epub 2013 Mar 25.

PMID:
23521373
43.

Frequency and prognostic impact of CEBPA proximal, distal and core promoter methylation in normal karyotype AML: a study on 623 cases.

Fasan A, Alpermann T, Haferlach C, Grossmann V, Roller A, Kohlmann A, Eder C, Kern W, Haferlach T, Schnittger S.

PLoS One. 2013;8(2):e54365. doi: 10.1371/journal.pone.0054365. Epub 2013 Feb 1.

44.

Temperature profile of radiofrequency probe application in wrist arthroscopy: monopolar versus bipolar.

Huber M, Eder C, Mueller M, Kujat R, Roll C, Nerlich M, Prantl L, Gehmert S.

Arthroscopy. 2013 Apr;29(4):645-52. doi: 10.1016/j.arthro.2012.11.006. Epub 2013 Feb 4.

PMID:
23380231
45.

ASXL1 exon 12 mutations are frequent in AML with intermediate risk karyotype and are independently associated with an adverse outcome.

Schnittger S, Eder C, Jeromin S, Alpermann T, Fasan A, Grossmann V, Kohlmann A, Illig T, Klopp N, Wichmann HE, Kreuzer KA, Schmid C, Staib P, Peceny R, Schmitz N, Kern W, Haferlach C, Haferlach T.

Leukemia. 2013 Jan;27(1):82-91. doi: 10.1038/leu.2012.262. Epub 2012 Sep 11.

PMID:
23018865
46.

SRSF2 mutations in 275 cases with chronic myelomonocytic leukemia (CMML).

Meggendorfer M, Roller A, Haferlach T, Eder C, Dicker F, Grossmann V, Kohlmann A, Alpermann T, Yoshida K, Ogawa S, Koeffler HP, Kern W, Haferlach C, Schnittger S.

Blood. 2012 Oct 11;120(15):3080-8. doi: 10.1182/blood-2012-01-404863. Epub 2012 Aug 23.

47.

A novel hierarchical prognostic model of AML solely based on molecular mutations.

Grossmann V, Schnittger S, Kohlmann A, Eder C, Roller A, Dicker F, Schmid C, Wendtner CM, Staib P, Serve H, Kreuzer KA, Kern W, Haferlach T, Haferlach C.

Blood. 2012 Oct 11;120(15):2963-72. doi: 10.1182/blood-2012-03-419622. Epub 2012 Aug 20.

PMID:
22915647
48.

Assessing impact and sustainability of health, water, and sanitation interventions in Bolivia six years post-project.

Eder C, Schooley J, Fullerton J, Murguia J.

Rev Panam Salud Publica. 2012 Jul;32(1):43-8.

PMID:
22910724
49.

G0/G1 switch gene-2 regulates human adipocyte lipolysis by affecting activity and localization of adipose triglyceride lipase.

Schweiger M, Paar M, Eder C, Brandis J, Moser E, Gorkiewicz G, Grond S, Radner FP, Cerk I, Cornaciu I, Oberer M, Kersten S, Zechner R, Zimmermann R, Lass A.

J Lipid Res. 2012 Nov;53(11):2307-17. doi: 10.1194/jlr.M027409. Epub 2012 Aug 13.

50.

GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis.

Fasan A, Eder C, Haferlach C, Grossmann V, Kohlmann A, Dicker F, Kern W, Haferlach T, Schnittger S.

Leukemia. 2013 Feb;27(2):482-5. doi: 10.1038/leu.2012.174. Epub 2012 Jul 3. No abstract available.

PMID:
22814295

Supplemental Content

Support Center